Hyperfine HYPR
NASDAQ HYPR
$0.89 +0.02 (+2.30%)
At close: Oct 2, 2026 · 4:00 PM EDT

Hyperfine (HYPR) Return on Sales [ROS] (2021 - 2026)

Updated

Hyperfine's Return on Sales [ROS] was -216.93% in Q2 2026, up 138.97 percentage points from -355.90% a year earlier and up 2.34 percentage points from the prior quarter.

Analysis

Hyperfine (HYPR) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Hyperfine's Return on Sales [ROS] was -203.27% through Jun 30, 2026, up 187.81 percentage points year-over-year; for FY2025, it came in at -273.43%, up 61.90 percentage points from FY2024.

  • Return on Sales [ROS] has now increased for five consecutive years, with a five-year change of +7716.71 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -335.33% in FY2024 (+100.81 pp), -436.14% in FY2023 (+648.01 pp), -1084.15% in FY2022 (+3251.95 pp) and -4336.10% in FY2021 (+3654.04 pp).
  • Quarterly Return on Sales [ROS] has moved between -5983.26% (Q4 2021) and -144.87% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for four straight quarters, with an average year-over-year change of +89.87 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2022 (a gain of 5026.16 percentage points); the worst was Q1 2025 (a drop of 186.94 percentage points).
  • Per Business Quant data, HYPR's Return on Sales [ROS] in the three quarters before Q2 2026 was -219.27% (Q1 2026), -144.87% (Q4 2025) and -259.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 Hyperfine 80.98 Mn -59.91 Mn 1.98 Mn -216.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -216.93%
Mar 31, 2026 -219.27%
Dec 31, 2025 -144.87%
Sep 30, 2025 -259.53%
Jun 30, 2025 -355.90%
Mar 31, 2025 -510.15%
Dec 31, 2024 -463.81%
Sep 30, 2024 -300.93%
Jun 30, 2024 -298.71%
Mar 31, 2024 -323.22%
Dec 31, 2023 -432.95%
Sep 30, 2023 -504.68%
Jun 30, 2023 -345.81%
Mar 31, 2023 -494.69%
Dec 31, 2022 -957.09%
Sep 30, 2022 -565.67%
Jun 30, 2022 -1,512.85%
Mar 31, 2022 -1,575.28%
Dec 31, 2021 -5,983.26%
Sep 30, 2021 -4,417.79%
API Access

Hyperfine Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HYPR&period=max&api_key=YOUR_API_KEY